Fall immunization update
Phase one of the Fall Immunization program rolled out on October 1. It focuses on offering the COVID-19 vaccine, free of charge, to eligible Albertans. Phase two begins October 20. Those eligible for the free vaccine in phase one include: - Healthcare workers (see full details here)
- All residents of continuing care homes and seniors supportive living accommodations
- Homebound home care clients
- Individuals six months of age and older with underlying medical or immunocompromising conditions
- Individuals experiencing homelessness
- Individuals 65 years of age and older receiving the Alberta Seniors Benefit.
The RSV vaccine will be available to those 60 years of age and older living in continuing care and seniors supportive living settings, as well as First Nations, Métis and Inuit individuals who are 60 years of age and older. All Albertans 70 years of age and older are eligible for the RSV vaccine.
Important lab bulletin: Change in respiratory virus test requisitions
Effective October 14, the only paper requisition accepted by Alberta Precision Laboratories for COVID-19, influenza and Respiratory Pathogen Panel (RPP) requests will be the COVID-19 and Other Respiratory Viruses Requisition. Primary care providers are reminded that community patients with symptoms qualify for routine COVID-19 and influenza testing. Please note that: - Requests using other paper requisitions will be cancelled.
- You must check off the testing required. Written test requests will not be accepted.
- You must complete the mandatory “Specify Test,” “Clinical History” and “RPP Criteria” fields on the requisition, along with any other relevant clinical information. If any of these fields are not completed, testing may be delayed and/or cancelled.
Read the full lab bulletin here.
Primary care providers needed to review urology pathways
This October, the Provincial Urology Working Group is coming together to review data and feedback on Alberta’s suite of clinical, patient and referral urology pathways. You’re undoubtedly busy, but insights from primary care providers are invaluable. Whether it’s a small tweak or a big idea, the pathways team wants to hear from you! Please check out these urology pathways and offer your insights. Send your thoughts on any of the pathways to: albertapathways@primarycarealberta.ca. Let’s make these pathways work better for patients, providers, and the system. Thanks for being part of the change! Fall immunization program phase two
APL lab bulletin for Calgary & South: Dermatophyte test change
Effective October 21, Alberta Precision Laboratories (APL) in Calgary will begin testing for dermatophyte fungi from skin scrapings and nail samples using nucleic acid amplification testing. Ongoing validation of hair samples will continue for six to 12 months, after which the new process will also be implemented if acceptable performance is demonstrated. If you’re ordering using the APL microbiology requisition, please ensure you’re using the latest version.
APL lab bulletin: Changes to transfusion test menus The Provincial Transfusion Medicine service has adopted a centralized support model linking immunohematology reference labs to all other Transfusion Medicine testing labs. Transfusion Medicine Labs are now classified into Non-Automated Testing Sites, Automated Testing Sites, Regional Testing Hubs, and Immunohematology Reference Labs. These sites come with new standardized testing menus that may result in a loss of some testing for some sites, or new and additional testing for some sites. Turn-around times may be affected.
APL lab bulletin: Discontinuation of stool WBC testing
Effective immediately, microscopy of stool for white blood cells (stool WBC or fecal leukocytes) will be discontinued provincially due to the availability of improved diagnostic tests. Any test requests for stool white blood cells will be cancelled.
APL lab bulletin: New restrictions on daily lab orders Effective October 21, Connect Care will implement restrictions on the use of daily lab orders for inpatients, to reduce unnecessary testing and improve patient care. The default number of occurrences will be set to three days, with a maximum of seven days. Please review and adjust personalized orders to align with the new limits.
APL lab bulletin: Change in Hemoglobin A1c testing
Effective October 21, all lab sites reporting Hemoglobin A1c (HbA1c) in Alberta will transition from the third-generation Roch Diagnostics HbA1c assay to the fourth-generation Roche HbA1c assay. Results exceeding 18.3% will be reported as >18.3%. There is no change to ordering, sample collection or routing processes.
|